<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib1665">
 <element-citation publication-type="journal" id="sbref1665">
  <person-group person-group-type="author">
   <name>
    <surname>Zahran</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Hetta</surname>
    <given-names>H.F.</given-names>
   </name>
   <name>
    <surname>Rayan</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Eldin</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Hassan</surname>
    <given-names>E.A.</given-names>
   </name>
   <name>
    <surname>Fakhry</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Soliman</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>El‑Badawy</surname>
    <given-names>O.</given-names>
   </name>
  </person-group>
  <article-title>Differential expression of Tim‑3, PD‑1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus‑related hepatocellular carcinoma and their impact on treatment outcomes</article-title>
  <source>Cancer Immunol. Immunother.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1007/s00262-019-02465-y</pub-id>
  <comment>in press</comment>
 </element-citation>
</ref>
